PMID: 11910262Mar 23, 2002Paper

Differential time course of cytochrome P450 2D6 enzyme inhibition by fluoxetine, sertraline, and paroxetine in healthy volunteers

Journal of Clinical Psychopharmacology
Heidi L ListonJuliet Goldman

Abstract

The selective serotonin reuptake inhibitors (SSRIs) paroxetine, sertraline, and fluoxetine have varying degrees of potency in inhibiting the hepatic cytochrome P450 (CYP) 2D6 enzyme. However, the time course for maximum inhibition to occur or for inhibition to dissipate when dosing is discontinued, requires clarification. In an open label, parallel group study of 45 healthy volunteers, the time course of CYP2D6 inhibition of the above SSRIs was evaluated. Subjects were randomized to receive paroxetine at 20 mg/day for 10 days; sertraline at 50 mg/day for 3 days, followed by sertraline at 100 mg/day for 10 days; or fluoxetine at 20 mg/day for 28 days. CYP2D6 activity was assessed using the dextromethorphan metabolic ratio (DMR) on antidepressant days 5 and 10 for sertraline and paroxetine and at weekly intervals for fluoxetine. Following SSRI discontinuation, calculation of a CYP2D6 inhibition half-life (t(1/2)inh) revealed the time course of fluoxetine inhibition (t(1/2)inh = 7.0 +/- 1.5 days) to be significantly longer than either paroxetine (t(1/2)inh = 2.9 +/- 1.9) or sertraline (t(1/2)inh = 3.0 +/- 3.0) (p < 0.01), but the latter were not significantly different from each other (p > 0.05). Time for the extrapolated DMR vers...Continue Reading

References

Mar 1, 1992·Clinical Pharmacology and Therapeutics·S H SindrupT C Tasker
Mar 1, 1992·Clinical Pharmacology and Therapeutics·R F BergstromL Lemberger
Aug 1, 1996·Journal of Clinical Psychopharmacology·A T Harvey, S H Preskorn
Oct 1, 1996·Journal of Clinical Psychopharmacology·A T Harvey, S H Preskorn
Aug 1, 1997·Journal of Clinical Psychopharmacology·J AldermanM Chung
Aug 1, 1997·Clinical Pharmacology and Therapeutics·D L KurtzB J Cerimele
Aug 15, 1997·Journal of Chromatography. B, Biomedical Sciences and Applications·J M HoskinsA S Gross
Apr 22, 1999·Journal of Clinical Psychopharmacology·C L AlfaroL Ereshefsky
Apr 1, 1997·Journal of Clinical Psychopharmacology·B A SprouleE M Sellers

❮ Previous
Next ❯

Citations

Jul 5, 2003·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·Jennifer L DonovanJohn S Markowitz
Jul 19, 2006·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·C Lindsay DeVane
Apr 14, 2011·Journal of Child and Adolescent Psychopharmacology·Chadi Albert Calarge, Del D Miller
Nov 28, 2002·Clinical Pharmacokinetics·C Lindsay DeVaneJohn S Markowitz
May 20, 2003·CNS Drugs·Leah M HesseDavid J Greenblatt
Nov 26, 2011·Expert Review of Clinical Pharmacology·Hiromitsu ImaiKyoichi Ohashi
Mar 19, 2008·Expert Opinion on Pharmacotherapy·Siu Wa Tang, Daiga Helmeste
May 27, 2009·Expert Opinion on Drug Metabolism & Toxicology·Zhi-Wei Zhou, Shu-Feng Zhou
Oct 31, 2007·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·K VenkatakrishnanA Rostami-Hodjegan
Nov 17, 2009·Basic & Clinical Pharmacology & Toxicology·Marjo VolotinenJukka Mäenpää
Aug 25, 2004·European Journal of Pain : EJP·Roger B Fillingim, Robert W Gear
Feb 27, 2013·Journal of Clinical Pharmacy and Therapeutics·J Juřica, A Žourková
Jun 11, 2014·British Journal of Clinical Pharmacology·Rashmi R Shah, Robert L Smith
Apr 8, 2006·Journal of the American Academy of Child and Adolescent Psychiatry·Stan KrulewiczKaren Dineen Wagner
Sep 4, 2016·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Luc R A RougéeStephen D Hall
Nov 3, 2016·Chemical & Pharmaceutical Bulletin·Dong-Wook KimKyung-Tae Lee
Feb 16, 2006·Journal of Psychopharmacology·Linh M VanAmin Rostami-Hodjegan
Apr 28, 2004·The Pharmacogenomics Journal·A Serretti, P Artioli
Aug 3, 2018·Drug Metabolism and Personalized Therapy·Shahin NilchiYalda H Ardakani
Sep 17, 2008·Journal of Clinical Psychopharmacology·Brian O'MathúnaRafael de la Torre
Dec 19, 2019·Pharmacogenetics and Genomics·Rachel HuddartTeri E Klein
Mar 6, 2012·Journal of Clinical Psychopharmacology·Marcel GerbauletNorbert Dahmen
Nov 10, 2006·Drug Metabolism and Disposition : the Biological Fate of Chemicals·R Scott ObachKarthik Venkatakrishnan
Aug 21, 2004·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Jennifer L DonovanJohn S Markowitz
Jun 2, 2020·Frontiers in Pharmacology·Charleen G Don, Martin Smieško
Aug 26, 2004·Drug Metabolism and Disposition : the Biological Fate of Chemicals·A HeydariA Rostami-Hodjegan
Mar 25, 2005·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Karthik Venkatakrishnan, R Scott Obach
Aug 26, 2004·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Jennifer L DonovanJohn S Markowitz
Jan 28, 2021·Pharmaceutics·Malavika DeodharVeronique Michaud
Dec 29, 2020·Frontiers in Genetics·Beatriz Carvalho HenriquesKatherine J Aitchison

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.